Cohere acquires Reliant AI to expand sovereign enterprise AI for the global biopharma and healthcare sectors

Cohere's acquisition of Reliant AI aims to enhance its position as a leader in sovereign AI by integrating Reliant's expertise in biomedical data and domain-optimized technology into its platform, significantly expanding its reach in the healthcare and life sciences sectors. This strategic move is designed to address the industry's stringent requirements for security, data privacy, and regulatory compliance, building on Cohere's existing presence in Canada, Germany, and Europe. The collaboration will enable healthcare and biopharma enterprises to leverage advanced AI technology and secure deployment options, enhancing processes and accelerating projects to market. Reliant AI's flagship product, an intelligent research workbench, is already used by global biopharma organizations to streamline literature reviews, competitive analysis, and data extraction, thereby expediting decision-making and market readiness. The deal also involves the development of North for Pharma, a specialized AI system to boost productivity in biopharma research and development, further expanding Cohere's North offerings for regulated industries. With Reliant AI's leadership joining Cohere in key roles, the acquisition promises to scale biopharma AI solutions globally, maintaining the necessary security and sovereignty for life sciences organizations.